Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$0.38 - $0.72 $83 - $157
219 Added 0.09%
246,670 $106,000
Q4 2022

Feb 13, 2023

SELL
$0.85 - $16.65 $510 - $9,990
-600 Reduced 0.24%
246,451 $261,000
Q2 2022

Aug 12, 2022

BUY
$1.19 - $2.0 $1,712 - $2,878
1,439 Added 0.59%
247,051 $358,000
Q3 2021

Nov 12, 2021

BUY
$2.7 - $3.59 $21,670 - $28,813
8,026 Added 3.38%
245,612 $736,000
Q2 2021

Aug 13, 2021

BUY
$3.21 - $4.06 $201,472 - $254,821
62,764 Added 35.9%
237,586 $871,000
Q1 2021

May 12, 2021

BUY
$3.7 - $6.42 $646,841 - $1.12 Million
174,822 New
174,822 $713,000

Others Institutions Holding MBRX

About Moleculin Biotech, Inc.


  • Ticker MBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,606,700
  • Market Cap $48.6M
  • Description
  • Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs....
More about MBRX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.